Literature DB >> 32955535

Effects of EGCG on depression-related behavior and serotonin concentration in a rat model of chronic unpredictable mild stress.

Guangjian Li1, Jing Yang2, Xu Wang1, Chen Zhou3, Xiangyu Zheng1, Weihong Lin1.   

Abstract

The aim of this study is to examine the antidepressant-like effect of EGCG and get deeper insights into implications of modulating serotonin (5-HT) in the colon and brain. A total of 24 stochastically-selected rats were subdivided into three groups: one group served as the control group, and other two groups were subjected to chronic unpredictable mild stress interventions (CUMS group and CUMS + EGCG group respectively). Before conducting a designed set of behavior tests, all rats were weighed and then forced swimming test (FST) and open field test (OPT) were performed in all rats for the measurement and analysis of central and colonic serotonin levels. In order to determine the extent of CUMS-induced injuries and examine neurological deficits, the method of Nissl staining was implemented accordingly. Meanwhile, haematoxylin-eosin (H&E) staining was employed to detect the structure of the colon. The study found that, due to the involvement of CUMS, the body weight of experimental rats declined, their time of immobility in FST was greater, and the avoidance of central sections in OPT was also greater and more obvious. However, through intervention of the EGCG treatment, either weight loss or depression-related behavior induced by the involvement of CUMS was alleviated in the experimental rats. Comparison of both CUMS and CUMS + EGCG groups indicated that EGCG administration may decrease the level of serotonin (5-HT) in the colon but increase the level of serotonin (5-HT) in the hippocampus. However, it should be noted that the level of 5-HT in peripheral blood did not show any significant difference between both groups. Furthermore, CUMS caused the morphological changes of the hippocampus and structural changes of the colon were noteworthy. Summarily, the investigation results of this experimental study indicated that the intervention of EGCG treatment might have considerable implications in several aspects such as anti-depression, regulation of 5-HT concentration, enhancement of intestinal hyper-permeability, and neuroprotection in the hippocampus.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32955535     DOI: 10.1039/d0fo00524j

Source DB:  PubMed          Journal:  Food Funct        ISSN: 2042-6496            Impact factor:   5.396


  4 in total

1.  Involvement of serotonergic neurotransmission in the antidepressant-like effect elicited by cholecalciferol in the chronic unpredictable stress model in mice.

Authors:  Vivian B Neis; Isabel Werle; Morgana Moretti; Priscila B Rosa; Anderson Camargo; Yasmim de O Dalsenter; Nicolle Platt; Axel F Rosado; William D Engel; Gudrian Ricardo L de Almeida; Ingrid Selhorst; Alcir Luiz Dafre; Ana Lúcia S Rodrigues
Journal:  Metab Brain Dis       Date:  2022-04-18       Impact factor: 3.655

Review 2.  Biological Role of Nutrients, Food and Dietary Patterns in the Prevention and Clinical Management of Major Depressive Disorder.

Authors:  Miguel A Ortega; Óscar Fraile-Martínez; Cielo García-Montero; Miguel Angel Alvarez-Mon; Guillermo Lahera; Jorge Monserrat; Maria Llavero-Valero; Luis Gutiérrez-Rojas; Rosa Molina; Roberto Rodríguez-Jimenez; Javier Quintero; Melchor Alvarez De Mon
Journal:  Nutrients       Date:  2022-07-28       Impact factor: 6.706

3.  The antidepressant effects and serum metabonomics of bifid triple viable capsule in a rat model of chronic unpredictable mild stress.

Authors:  Qinpeng Bu; Jingkai Zhang; Xiang Guo; Yifei Feng; Huan Yan; Weimin Cheng; Zhitao Feng; Meiqun Cao
Journal:  Front Nutr       Date:  2022-09-15

4.  Effect of Epigallocatechin-3-gallate on Stress-Induced Depression in a Mouse Model: Role of Interleukin-1β and Brain-Derived Neurotrophic Factor.

Authors:  Nabila E Abdelmeguid; Tasneem M Hammad; Ashraf M Abdel-Moneim; Sherine Abdel Salam
Journal:  Neurochem Res       Date:  2022-08-08       Impact factor: 4.414

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.